Baker Bros. Advisors LP Cabaletta Bio, Inc. Transaction History

Baker Bros. Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.21 - $23.36 $19.3 Million - $36.9 Million	-1,580,669 Reduced 99.16%	13,331 $302,000
Q2 2023 Aug 14, 2023	BUY	$7.65 - $13.95 $1.91 Million - $3.49 Million	250,000 Added 18.6%	1,594,000 $20.6 Million
Q4 2022 Feb 14, 2023	BUY	$0.64 - $9.3 $436,439 - $6.34 Million	681,937 Added 103.0%	1,344,000 $12.4 Million
Q3 2021 Nov 15, 2021	BUY	$7.0 - $12.5 $179,900 - $321,250	25,700 Added 4.04%	662,063 $8.05 Million
Q4 2019 Feb 14, 2020	BUY	$7.88 - $17.71 $5.01 Million - $11.3 Million	636,363 New	636,363 $8.89 Million

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.